Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Patient, tumor, and treatment characteristics

From: Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer

Characteristic

No. of Pts (%) (n = 45)

Median age at diagnosis, years (range)

47 (29–82)

Tumor Histology, n (%)

 

Squamous Cell

Carcinoma

40 (89%)

Adenocarcinoma/ Adenosquamous

5 (11%)

FIGO Stage, n (%)

 

I

0

II

13 (29%)

III

22 (49%)

IV

10 (22%)

Chemotherapy cycles, median (range)

6 (2–6)

HR-CTV size in cc, median (range)

76.2 (30.4- 356.3)

90th percentile ADC, median (range)

2.35 (1.79–3.56)

Complete Metabolic Response

 

Yes

28 (62%)

No

17 (38%)

  1. Abbreviations: FIGO = International Federation of Gynecology and Obstetrics; HR-CTV = high risk clinical target volume; ADC = apparent diffusion coefficient